Top Markets
#1 Akedo Akedo +54.88%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.11%
#4 Velvet Velvet +43.34%
#5 Black Phoenix Black Phoenix +34.52%
#6 τemplar τemplar +22.75%
#7 Cross Cross +19.33%
#8 Ribbita by Virtuals Ribbita by Virtuals +16.59%
#9 Bitway Bitway +15.40%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.38%
Coin of the day
Akedo Akedo
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Geffen Residence & Renewal Ltd Geffen Residence & Renewal Ltd

Geffen Residence & Renewal Ltd

GEFR
Rangering i aksjer #38275
Geffen Residence & Renewal Ltd, previously known as Cannomed Medical Cannabis... Geffen Residence & Renewal Ltd, previously known as Cannomed Medical Cannabis Industries Ltd, is a company with a dual focus based in Tel Aviv-Yafo, Israel, established in 1999. It plays a significant role in the Israeli medical cannabis market, overseeing the growth, manufacturing, storage, distribution, and retail of these products. Additionally, the company operates a chain of pharmacies that offer a wide array of merchandise. These retail outlets provide personal care items, cosmetics, and various convenience goods. Their pharmaceutical offerings include prescription and over-the-counter medications, alongside natural health products, vitamins, and supplements. The pharmacies also stock first-aid supplies like plasters and bandages, as well as health monitoring devices such as thermometers and humidifiers.
Aksjekurs
$0.26456612
Markedsverdi
$1.09M
Endring (1 dag)
1.24%
Endring (1 år)
13.83%
Land
IL
Handel Geffen Residence & Renewal Ltd (GEFR)

Kategori

Healthcare
Inntekter for Geffen Residence & Renewal Ltd (GEFR)
Inntekter i 2026 TTM: 0
Ifølge Geffen Residence & Renewal Ltd sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Geffen Residence & Renewal Ltd fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE